Search

everythinglearnresearchcommunity

for

Search:↓

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

The document provides ways to tell alopecia areata from other similar hair loss conditions, using visual checks and specific tests.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Finasteride's effectiveness on the frontal hair loss area is not well-studied or confirmed.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

The conclusion is that an algorithm using trichoscopy helps diagnose different types of hair loss but may need updates and a biopsy if results are unclear.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

The woman's hair loss pattern doesn't match typical conditions like alopecia areata or female pattern hair loss.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

A woman's hair loss led to discovering she had lupus.

Hominis Placenta Pharmacopunture helped regrow hair in a patient with stress-induced hair loss.

Hair transplantation is effective for seborrheic hair loss if done carefully.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Higher levels of certain nerve-related proteins are linked to hair loss in women with scalp pain.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Microneedle-assisted therapy with human basic fibroblast growth factor significantly regrew hair in patients with hair loss.

Higher levels of certain proteins in hair loss areas may help understand and treat hair loss.

Betamethasone is more effective for hair regrowth than latanoprost but has more side effects.

Hair diameter difference, brown skin discoloration around hair follicles, and missing hair in certain areas are key signs of androgenetic alopecia (commonly known as hair loss) when viewed under a dermoscope.

Higher STAT3 levels are found in hair loss areas, but not linked to hair loss severity.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

Gushen Shengfa pills and Wuling capsules are more effective for hair growth and sleep quality than the control treatment.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

Hair transplantation effectively treats burn scar alopecia, improving self-esteem and confidence.

The method is effective for evaluating hair loss treatments quickly and affordably.